BSE filing, BSE: 524548. Summary written from the filing by ALFA Finder's alert engine.
Sharma East India Hospitals & Medical Research Ltd: key numbers
- Share price
- ₹80.48
- Market cap
- ₹26.43 Cr
- Revenue (annual)
- ₹35.93 Cr
- Net profit (annual)
- ₹1.24 Cr
- P/E (TTM)
- 22.3×Sector 51.1×
- Promoter holding
- 53.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharma East India Hospitals & Medical Research Ltd
All →Sharma East India Hospitals & Medical Research Annual General Meeting
Sharma East India Hospitals & Medical Research Ltd. conducted its 37th Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary business resolutions.
Sharma East India Hospitals & Medical Research Annual Report
Sharma East India Hospitals has filed its 37th Annual Report for FY 2025-2026. The report includes details concerning the upcoming Annual General Meeting.
Sharma East India Hospitals & Medical Research Annual General Meeting
The company approved its Annual Report and scheduled the 37th Annual General Meeting for September 30, 2026. Various AGM-related procedural dates were also finalized.
Sharma East India Hospitals & Medical Research Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.8 Cr (+13.7% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY
Sharma East India Hospitals & Medical Research Board Meeting Date
Sharma East India Hospitals will hold a board meeting on August 12, 2026, to approve the standalone un-audited financial results for the quarter ended June 30, 2026.
Sharma East India Hospitals & Medical Research Other Announcement
The company has filed its quarterly shareholding pattern as per SEBI regulations. This document discloses the current distribution of shareholding among various categories.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.